Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeadaches are a recognised side effect of semaglutide, reported by a meaningful proportion of people in clinical trials — but they are rarely the whole story, and they rarely last. If you've started Wegovy and noticed a dull ache behind your eyes or a tension headache that wasn't there before, you're not imagining it. These medicines work partly by slowing gastric emptying and suppressing appetite, which changes how much you eat and drink; that shift alone can trigger headaches in the early weeks. They are a prescription-only medicine requiring clinical assessment before any treatment begins, and our prescribers walk through side effects like this as part of every consultation at nume.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The instinctive assumption when a new medicine causes a headache is that the drug is doing something neurological. With semaglutide, that's usually not what's happening. The more common culprits are indirect: eating considerably less than before, drinking less fluid because you feel full, and the body adjusting to a new metabolic rhythm. GLP-1 receptor agonists slow stomach emptying significantly, so both calories and hydration can drop sharply in the first weeks, conditions that reliably produce headaches in almost anyone, medicine or not.
The NHS medicines information for semaglutide lists headache as a common side effect, meaning it affects between 1 in 10 and 1 in 100 people. That's common enough to be worth knowing about, not so common that it defines the experience. Most people who do get headaches on Wegovy describe them as tension-type, low-grade, and time-limited, peaking in the first week or two and fading as eating and drinking patterns stabilise, and if you want to understand how Wegovy and headaches tend to relate across that early period, the picture becomes clearer when you look at what's actually driving them. If you want a fuller picture of how quickly the body begins to adjust, our page on the semaglutide side-effect timeline maps the typical arc from week one onwards.
Practical measures matter here. Staying well hydrated (more than you think you need when nausea is suppressing your thirst) and maintaining regular, protein-adequate meals (even small ones) removes the most common triggers. That's not a workaround; it's just physiology.
Wegovy's escalation schedule moves from 0.25mg through 0.5mg, 1.0mg and 1.7mg up to a 2.4mg maintenance dose, with each step typically taken around four weeks apart. Headaches can resurface at each step for the same indirect reasons: the appetite-suppressing effect intensifies, intake drops again, and the body recalibrates. If you're wondering whether Wegovy causes headaches or whether something else is going on, the dose-escalation pattern is usually a good place to start looking for an explanation.
The distinction to hold in mind is between a familiar tension headache that responds to hydration and rest, and a headache that's new in character, notably different in location, severity or the way it came on. A sudden, severe headache that feels unlike any you've had before is not a semaglutide adjustment headache; it needs same-day medical attention regardless of what medicines you're taking.
Our overview of Wegovy side effects puts headache in context alongside the more frequently discussed gastrointestinal symptoms, nausea, constipation and reflux get most of the attention, but headache often catches people off guard because it feels unrelated to a weight-loss medicine. It's a reasonable thing to raise with your prescriber at any point. At nume, clinical review doesn't stop after the first pen arrives; aftercare is built in, seven days a week.
This is the part that deserves plain language. Most semaglutide headaches don't need a GP call. They need water, food and a little time. But some do.
Seek prompt medical attention if you experience: a headache that is sudden and severe (sometimes described as the worst of your life); headache with visual disturbance, slurred speech or facial drooping; headache alongside signs of severe dehydration, dark urine, dizziness on standing, rapid heart rate from repeated vomiting or diarrhoea; or persistent headache that doesn't respond to over-the-counter analgesia and is getting worse over days.
The MHRA's January 2026 Drug Safety Update on GLP-1 medicines also flags acute pancreatitis as a separate serious side effect to be aware of: severe stomach pain that radiates to the back, with or without vomiting, is the key symptom, not a headache, but worth knowing if you're reading up on safety. Our page covering semaglutide headache in detail is a useful reference if you want to separate the expected from the symptoms that genuinely warrant a call. You can report any unexpected side effect through the Yellow Card scheme, which is how post-market safety signals get identified and acted on. Your report matters.
If you're uncertain whether your symptoms are typical, the honest answer is: contact your prescriber. Our support team is available seven days a week for exactly this kind of question.
Wegovy is a prescription-only medicine. Getting it through a GPhC-registered pharmacy means a real clinician has reviewed your health history before a single pen is dispensed, not software making a binary decision, but a qualified prescriber reading your answers and deciding whether treatment is appropriate for you, including flagging anything in your profile that might affect how side effects land.
At nume, a GPhC-registered Independent Prescriber reviews every consultation the same day it's submitted. If you order before noon on a working day and your prescription is approved, your treatment is dispatched that afternoon through DPD, tracked to your door the next working day, in plain unbranded packaging. The pen itself is a pre-filled device; no mixing, no measuring. It comes with a patient information leaflet that covers every side effect in detail, and our prescribers are the right people to call if something in those pages concerns you.
If you're weighing up whether Wegovy is right for your situation, our Wegovy overview covers the full picture, licence, eligibility, evidence and how private treatment works. And if you'd like to explore all available weight-loss treatment options before deciding, that's a reasonable place to start too. Check your eligibility whenever you're ready, there's no commitment in the consultation itself.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.